Fernanda Marconi Roversi

BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Fernando Vieira Pericole, Mariana Lazarini, Luciana Bueno de Paiva et al. · Frontiers in Oncology · 2019 · 45 citations · Full text

Blood oxidative stress markers in Gaucher disease patients

Fernanda Marconi Roversi, Luciano Galdieri, Bruno H.C. Grego et al. · Clinica Chimica Acta · 2005 · 40 citations

Lipid Peroxidation, Reactive Oxygen Specie, Oxidative Stress +1

Hematopoietic cell kinase (HCK) is a potential therapeutic target for dysplastic and leukemic cells due to integration of erythropoietin/PI3K pathway and regulation of erythropoiesis

Fernanda Marconi Roversi, Fernando Vieira Pericole, João Agostinho Machado‐Neto et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2016 · 33 citations · Full text

Potential Therapeutic Target, Hematological Malignancy, Leukemic Cells +11

SEMA3A partially reverses VEGF effects through binding to neuropilin-1

Bruna Palodetto, Adriana da Silva Santos Duarte, Matheus Rodrigues Lopes et al. · Stem Cell Research · 2017 · 24 citations · Full text

Up‐regulation of <scp>SPINT</scp>2/<scp>HAI</scp>‐2 by Azacytidine in bone marrow mesenchymal stromal cells affects leukemic stem cell survival and adhesion

Fernanda Marconi Roversi, Nathália Moreno Cury, Matheus Rodrigues Lopes et al. · Journal of Cellular and Molecular Medicine · 2018 · 17 citations · Full text